P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS

被引：17
|
作者：
Huber, Paula C. [1 ]
Maruiama, Cintia H. [1 ]
Almeida, Wanda P. [1 ]
机构：
[1] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13084971 Campinas, SP, Brazil
来源：
QUIMICA NOVA | 2010年 / 33卷 / 10期
关键词：
P-glycoprotein; multidrug resistance; modulators; DRUG-RESISTANCE; ABC TRANSPORTER; CELLS; INHIBITORS; BINDING; MODEL; MDR; COMBINATION; MECHANISMS; TARIQUIDAR;
D O I：
10.1590/S0100-40422010001000027
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS. Multidrug resistance, MDR is a major obstacle for cancer chemotherapy. MDR can be reversed by drugs that vary in their chemical structure and main biological activity. Many efforts have been done to overcome MDR based on studies of structure-activity relationships and in this review we summarize some aspects of MDR mediated by P-glycoprotein (P-gp), as the most experimentally and clinically tested form of drug resistance. The most significant MDR mechanisms revealed until now are shortly discussed. Physicochemical and structural properties of MDR modulators, measures of the MDR reversal, and QSAR studies are included.
引用
收藏
页码：2148 / 2154
页数：7
相关论文
共 50 条
  • [41] Studies of interactions between uracil-based hybrid molecules and P-glycoprotein - Search for multidrug resistance modulators
    Singh, Palwinder
    Paul, Kamaldeep
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (21) : 7183 - 7186
  • [42] Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships
    Bai, Jie
    Zhao, Shengyu
    Fan, Xiaoqing
    Chen, Yonghui
    Zou, Xiaowen
    Hu, Minwan
    Wang, Baolian
    Jin, Jing
    Wang, Xiaojian
    Hu, Jinping
    Zhang, Dan
    Li, Yan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 369 : 49 - 59
  • [43] Structure-Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein
    Jabeen, Ishrat
    Pleban, Karin
    Rinner, Uwe
    Chiba, Peter
    Ecker, Gerhard F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3261 - 3273
  • [44] Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors
    Voigt, Burkhardt
    Coburger, Claudius
    Monar, Josef
    Hilgeroth, Andreas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) : 5110 - 5113
  • [45] Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors
    Liu, Hongming
    Ma, Zhiguo
    Wu, Baojian
    XENOBIOTICA, 2013, 43 (11) : 1018 - 1026
  • [46] Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract
    Plouzek, CA
    Ciolino, HP
    Clarke, R
    Yeh, GC
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (10) : 1541 - 1545
  • [47] Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model
    Gombar, VK
    Polli, JW
    Humphreys, JE
    Wring, SA
    Serabjit-Singh, CS
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (04) : 957 - 968
  • [48] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN
    CALLAGHAN, R
    HIGGINS, CF
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 294 - 299
  • [49] P-GLYCOPROTEIN, MULTIDRUG-RESISTANCE AND TUMOR PROGRESSION
    BRADLEY, G
    LING, V
    CANCER AND METASTASIS REVIEWS, 1994, 13 (02) : 223 - 233
  • [50] EFFECTS OF PHOSPHORYLATION OF P-GLYCOPROTEIN ON MULTIDRUG-RESISTANCE
    GERMANN, UA
    CHAMBERS, TC
    AMBUDKAR, SV
    PASTAN, I
    GOTTESMAN, MM
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) : 53 - 61
12345